Home > products > phospholipids
> pegylation-phosphadylethanolamine-pe
> dspe-polyethylene-glycol-550-ckngre
DSPE-polyethylene glycol550-cKNGRE
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-cKNGRE
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-C-4326 | 50mg | 850.00 | + Add to cart |
|
R-C-4326 | 100mg | 1450.00 | + Add to cart |
|
R-C-4326 | 250mg | 2100.00 | + Add to cart |
|
|
Product description
Polypeptides, as receptor targeted anti-tumor carriers, are increasingly used to improve the effect of chemotherapy drugs. Experiments have also proved that they can enhance the targeted specificity of drugs, enhance the targeted absorption of drugs, improve the anti-tumor effect, and improve the original insoluble properties of some small molecule drugs. Peptide carrier targeting technology is known as a new generation of targeted drug development technology. Our products are only used for scientific research experiments, not for clinical experiments.
Appearance | N/A |
---|---|
PEG Molecular Weight | 550 |
purity | >95% |
PDI by GPC | <1.5 |
Solubility | N/A |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 3 weeks |
Stability | 2 years |
Document
Related Product